Skip to content

Comparative Clinical Study: Ayurvedic Formulations for Jaundice Management

A Randomized Comparative Clinical Study of Patoladi Ghan Vati And Navayasa Churna in The Management of Kamala W.S.R. to Jaundice - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075891
Enrollment
60
Registered
2024-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R17- Unspecified jaundice

Interventions

None listed

Sponsors

National Institute of Ayurveda, Deemed to be University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical signs and symptoms suggestive of Kamala i.e jaundice and subjects with total serum bilirubin greater than 3 mg per deciliter

Exclusion criteria

Exclusion criteria: 1. Patients having history of chronic illness more than 5 years. 2. Patients who have developed malignancy, cirrhosis, fulminant hepatitis and other complications. 3. Patients of obstructive and hemolytic jaundice. 4. Jaundice due to malaria, autoimmune disorders and leptospirosis

Design outcomes

Primary

MeasureTime frame
Changes in the Total Bilirubin.Timepoint: at baseline and end of 4th week.

Secondary

MeasureTime frame
Changes in Subjective Parameters like Avipak Aruchi daurbalya sadan Yakrit vriddhi Tilpishta sannibha mala chardi Jwar dahaTimepoint: at baseline At the end of 4th week

Countries

India

Contacts

Public ContactProf Ramkishor Joshi Sir

National Institute of Ayurveda

joshirk1964@gmail.com9414322297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026